BAKER BROS ADVISORS LLC Insider Trading $BLCM BELLICUM PHARMACEUTICALS, INC
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in BELLICUM PHARMACEUTICALS, INC
Trading Symbol: BLCMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 412,246 shares
Current Value: $5,181,932
Latest Transaction: Jan 19 2018
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in BELLICUM PHARMACEUTICALS, INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 7.91 | 4,136 | 32,715 | 58,131 | 62.3 K to 58.1 K (-6.64 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 7.91 | 265,708 | 2,101,671 | 3,734,776 | 4 M to 3.7 M (-6.64 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 7.91 | 25,517 | 201,832 | 358,671 | 384.2 K to 358.7 K (-6.64 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.12 | 4,548 | 36,910 | 62,267 | 66.8 K to 62.3 K (-6.81 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.12 | 292,168 | 2,371,148 | 4,000,484 | 4.3 M to 4 M (-6.81 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.12 | 28,058 | 227,710 | 384,188 | 412.2 K to 384.2 K (-6.81 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.63 | 3,649 | 31,476 | 66,815 | 70.5 K to 66.8 K (-5.18 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.63 | 234,437 | 2,022,230 | 4,292,652 | 4.5 M to 4.3 M (-5.18 %) |
Jan 19 2018 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | S | 8.63 | 22,514 | 194,204 | 412,246 | 434.8 K to 412.2 K (-5.18 %) |
Mar 28 2017 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 12.00 | 151,177 | 1,814,124 | 4,527,089 | 4.4 M to 4.5 M (+3.45 %) |
Mar 28 2017 | BLCM | BELLICUM PHARMACEU ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | P | 12.00 | 15,489 | 185,868 | 434,760 | 419.3 K to 434.8 K (+3.69 %) |
Page: 1